EMSN.SW stock climbed 3.91% to CHF 624.00 in after-hours trading as investors position ahead of Ems-Chemie’s earnings release scheduled 06 Feb 2026. We note a higher-than-average session volume of 20,335 shares and a year high of CHF 685.50, signaling investor attention. The move reflects expectations for margin commentary from the chemicals-specialty name listed on SIX in Switzerland and sets the stage for short-term volatility around the results.
EMSN.SW stock: after-hours price action and drivers
EMSN.SW stock rose to CHF 624.00, up 3.91%, with a session range CHF 612.50–626.00 and opening price CHF 623.00.
The uptick followed positioning ahead of the earnings announcement on 06 Feb 2026 and a pickup in relative volume (today 20,335 vs avg 13,230), implying traders expect news or guidance to matter for margins.
EMSN.SW stock: earnings expectations and catalysts
Ems-Chemie reports results on 06 Feb 2026, and investors will watch EPS, margin detail, and segment commentary for High Performance Polymers and Specialty Chemicals.
Consensus drivers include automotive demand, price pass-through in polymers, and raw-material cost trends that could swing operating margins.
EMSN.SW stock: valuation and key financials
EMSN.SW trades at PE 31.50 with EPS 19.78 and market cap CHF 14,571,364,444.00 reflecting premium valuation versus peers.
Balance-sheet metrics show extremely low leverage (debt/equity 0.01) and a strong current ratio 6.76, but price-to-book 7.03 and price-to-sales 7.27 indicate stretched multiples relative to the Swiss basic materials sector.
EMSN.SW stock: Meyka AI grade and technicals
Meyka AI rates EMSN.SW with a score of 70.00 out of 100 — Grade B+, Suggestion BUY.
This grade factors S&P 500 and sector comparisons, financial growth, key metrics, forecasts, and analyst signals. Technicals show RSI 67.54, MACD histogram 2.21, and CCI 277.08, implying short-term strength but overbought conditions.
EMSN.SW stock: short-term targets and Meyka AI forecast
Meyka AI’s forecast model projects a monthly price of CHF 612.07 and a yearly projection of CHF 516.76, signalling differing horizons for traders and investors.
Relative to the current price CHF 624.00, the monthly projection implies downside -1.91% and the yearly projection implies downside -17.19%, noting forecasts are model-based and not guarantees.
EMSN.SW stock: risks, sector context and catalysts to watch
Key risks include cyclical end-market exposure, raw-material volatility, and high valuation multiples that amplify disappointment on guidance.
In sector context, Swiss Basic Materials peers trade at average PE 17.67 while EMSN.SW sits at 31.50, so earnings must justify the premium to avoid a valuation reset.
Final Thoughts
Earnings are the immediate catalyst for EMSN.SW stock after the after-hours rise to CHF 624.00 on 05 Feb 2026. Short-term traders should watch EPS print, polymer segment margins, and management guidance for 2026. Valuation is rich with PE 31.50 and PB 7.03, so upside requires margin or growth surprises. Meyka AI’s model shows a near-term monthly forecast of CHF 612.07 and a one-year model value of CHF 516.76, implying downside over 12 months but limited near-term drift. Our view: expect volatility post-release; event-driven traders may target a tactical upside to CHF 660.00 for a short-term move, while longer-term investors should reconcile premium multiples with operational growth and dividend yield 2.77% in CHF. Forecasts are model-based projections and not guarantees, and Meyka AI is cited here as an AI-powered market analysis platform
FAQs
When does Ems-Chemie report results and how can that affect EMSN.SW stock?
Ems-Chemie reports earnings on 06 Feb 2026; results can move EMSN.SW stock on EPS, margin detail, and forward guidance, creating short-term volatility and trading opportunities
What are the key valuation numbers for EMSN.SW stock?
EMSN.SW stock trades at PE 31.50, EPS 19.78, PB 7.03, and dividend yield about 2.77%, reflecting a premium versus sector averages and higher growth expectations
What does the Meyka AI grade mean for EMSN.SW stock?
Meyka AI rates EMSN.SW 70/100 (Grade B+, Suggestion BUY); the score blends benchmark, sector, growth and forecast data; it is informational and not investment advice
What short-term price level should traders watch for EMSN.SW stock?
Traders may watch support near CHF 612.07 (Meyka monthly forecast) and resistance near CHF 660.00 as a tactical target after earnings; risk management is essential
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)